Workflow
LEGEND STRAT(01355)
icon
Search documents
朸浚国际(01355) - 2025 - 中期财报
2025-09-16 08:37
[CORPORATE INFORMATION](index=3&type=section&id=CORPORATE%20INFORMATION) [Directors and Committee Composition](index=3&type=section&id=Directors%20and%20Committees) The company's board of directors comprises executive, non-executive, and independent non-executive directors, supported by audit, nomination, and remuneration committees to ensure robust corporate governance - Executive Director is **Ms. Li Zhi Xin**[3](index=3&type=chunk) - Non-executive Directors include Chairman **Mr. Yuan Fuaer** and **Mr. Hu Xinglong**[3](index=3&type=chunk) - Independent Non-executive Directors include **Mr. Wu Jilin** (Audit Committee Chairman), **Mr. Lin Changsheng** (Nomination Committee Chairman), and **Mr. Su Yanwei** (Remuneration Committee Chairman)[3](index=3&type=chunk)[4](index=4&type=chunk) [Company Details](index=4&type=section&id=Company%20Details) The company's principal bankers include Industrial Bank in China and Hang Seng Bank, Bank of China (Hong Kong), and Bank of Communications (Hong Kong) in Hong Kong, with auditors being National Alliance CPA Limited and stock code 1355 - Principal bankers include **Industrial Bank Co., Ltd.** in China, and **Hang Seng Bank Limited**, **Bank of China (Hong Kong) Limited**, and **Bank of Communications (Hong Kong) Limited** in Hong Kong[5](index=5&type=chunk)[6](index=6&type=chunk) - Auditor is **National Alliance CPA Limited**[6](index=6&type=chunk)[7](index=7&type=chunk) - Company stock code is **1355**, website is **www.legend-strategy.com**[8](index=8&type=chunk)[9](index=9&type=chunk) [MANAGEMENT DISCUSSION AND ANALYSIS](index=6&type=section&id=MANAGEMENT%20DISCUSSION%20AND%20ANALYSIS) [Business Review](index=6&type=section&id=BUSINESS%20REVIEW) The Group primarily operates accommodation and healthcare and beauty businesses, with accommodation revenue declining by **28.9%** due to global instability, while healthcare and beauty contributed approximately **HKD 11,886,000** in revenue - The Group primarily engages in accommodation business (including accommodation operation, property facilities management, and accommodation consulting services) and healthcare and beauty business[10](index=10&type=chunk)[12](index=12&type=chunk) - For the six months ended June 30, 2025, the Group operated **five** leased accommodation projects[10](index=10&type=chunk)[12](index=12&type=chunk) [Accommodation Business](index=6&type=section&id=ACCOMMODATION%20BUSINESS) Accommodation business revenue decreased by **28.9%** year-on-year due to global economic instability and geopolitical conflicts, with the Nanshan store closure generating approximately **HKD 1,920,000** in early lease termination income - The hotel business continues to be affected by global economic instability and geopolitical conflicts, particularly China's economic slowdown and weakened consumer sentiment[11](index=11&type=chunk)[13](index=13&type=chunk) - The Group adopts flexible sales and marketing strategies to improve existing accommodation project performance and promotes sustainable high-quality corporate development through enhanced management, cost control, and expense reduction[11](index=11&type=chunk)[13](index=13&type=chunk) [Accommodation Operation and Property Facilities Management](index=7&type=section&id=Accommodation%20Operation%20and%20Property%20Facilities%20Management) Accommodation operation and property facilities management revenue was approximately **HKD 13,579,000**, a **28.9%** year-on-year decrease, primarily due to lower occupancy rates and reduced consulting service income in China's hotel market Accommodation Operation and Property Facilities Management Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 13,579,000 | 19,104,000 | -28.9% | - Revenue decrease primarily attributed to lower occupancy rates due to declining overall market sentiment in China's hotel industry, and reduced accommodation consulting service income[14](index=14&type=chunk)[18](index=18&type=chunk) - The Group enhances customer loyalty by collaborating with new travel intermediaries, updating sales strategies, offering preferential pricing models, deepening understanding of customer needs, and providing customized services[16](index=16&type=chunk)[19](index=19&type=chunk) [Branch Performance Overview](index=8&type=section&id=Branch%20Performance%20Overview) The Group's accommodation branches employ flexible strategies, with Chengdu benefiting from tourism recovery, Wuhan operating steadily, Huizhou anticipating Greater Bay Area growth, Nanshan generating **HKD 1,920,000** from lease termination, and Bao'an maintaining stability through cost control - The Chengdu store, located in the prime Tianfu Square business district, benefits from Chengdu's economic recovery and rebound in tourism consumer confidence, expecting sustained stable income in the future[20](index=20&type=chunk)[21](index=21&type=chunk)[22](index=22&type=chunk) - The Wuhan store, a transportation hub, experienced a slight demand decrease due to domestic economic development difficulties but achieved expected results in adversity through strengthened management, marketing, and cost optimization[23](index=23&type=chunk)[24](index=24&type=chunk)[26](index=26&type=chunk) - The Huizhou store, focusing on the resort tourism market, anticipates that Greater Bay Area development and international projects (such as Shenzhen East Legoland Theme Park) will drive tourist growth and long-term performance improvement[25](index=25&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk)[32](index=32&type=chunk) - The Nanshan store ceased operations due to property repossession by the landlord for redevelopment, with approximately **HKD 1,920,000** in early lease termination income recognized this period[30](index=30&type=chunk)[33](index=33&type=chunk) - The Bao'an store maintained stable operating performance in adversity, benefiting from effective cost control and sales strategies[34](index=34&type=chunk)[35](index=35&type=chunk)[40](index=40&type=chunk) [Accommodation Consulting Services](index=11&type=section&id=Accommodation%20Consultations%20Services) Accommodation consulting services generated zero revenue this period, a significant decline from the prior year, leading the Group to reduce marketing investment and reallocate resources to the more promising healthcare and beauty business Accommodation Consulting Services Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 0 | 1,126,000 | - Given the reduced demand for such services, the Group will decrease marketing investment to save operating costs and reallocate resources to the healthcare and beauty business segment[37](index=37&type=chunk)[41](index=41&type=chunk) [Healthcare and Beauty Business](index=11&type=section&id=HEALTHCARE%20AND%20BEAUTY%20BUSINESS) The Group, through its wholly-owned subsidiary Shenzhen Yalansi Biotechnology Co. Ltd., generated approximately **HKD 11,886,000** in revenue this period by directly selling and promoting own-brand and third-party healthcare and beauty products in China - The Group will continue to develop its healthcare and beauty business through collaborations with key industry players and the development of proprietary rights and technologies[38](index=38&type=chunk)[42](index=42&type=chunk) Healthcare and Beauty Business Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 11,886,000 | 0 | - During this period, this business generated approximately **HKD 11,886,000** in revenue by directly selling and promoting own-brand products in China through Shenzhen Yalansi Biotechnology Co. Ltd.[39](index=39&type=chunk)[42](index=42&type=chunk) [Outlook](index=12&type=section&id=OUTLOOK) The Group plans to expand its market share in China's healthcare and beauty sector and explore international sales, considering an equity acquisition of an R&D platform for technology and competitive advantage, though no final agreement has been reached - The Group will further develop and strengthen its market share in China's healthcare and beauty industry and seek opportunities to expand sales to other regions[44](index=44&type=chunk)[47](index=47&type=chunk) - The Group is considering acquiring an equity interest in an R&D platform to gain cutting-edge technology and maintain a competitive advantage[44](index=44&type=chunk)[47](index=47&type=chunk) - As of the date of this interim report, no decision has been made or final agreement reached regarding the potential acquisition, and shareholders and potential investors are urged to exercise caution[45](index=45&type=chunk)[47](index=47&type=chunk) [Financial Review](index=12&type=section&id=FINANCIAL%20REVIEW) The Group's revenue increased by **33.2%** to approximately **HKD 25,445,000** this period, driven by healthcare and beauty, but a decline in accommodation revenue and non-financial asset impairment led to a **HKD 13,484,000** loss attributable to owners [Overall Financial Performance](index=12&type=section&id=Overall%20Financial%20Performance) The Group's revenue reached approximately **HKD 25,445,000**, a **33.2%** year-on-year increase, but reduced accommodation income and a **HKD 8,340,000** non-financial asset impairment resulted in a **HKD 13,484,000** loss attributable to owners, compared to a prior year profit of **HKD 3,211,000** Key Financial Indicators | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 25,445,000 | 19,104,000 | +33.2% | | Loss/(Profit) Attributable to Owners | (13,4
朸浚国际(01355) - 截至二零二五年八月三十一日止股份发行人的证券变动月报表
2025-09-10 03:24
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 朸濬國際集團控股有限公司 呈交日期: 2025年9月10日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01355 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | FF3 ...
朸濬国际(01355)拟折让11.27%配售最多1.99亿股 净筹约1237万港元
Zhi Tong Cai Jing· 2025-09-08 12:49
Core Viewpoint - The company, Pochun International (01355), plans to issue up to 199 million shares at a discount of approximately 11.27% to raise around HKD 12.37 million for the further development of its healthcare and beauty business [1] Group 1 - The company has entered into a placement agreement with a placement agent to facilitate the sale of shares [1] - The placement price is set at HKD 0.063 per share, compared to the closing price of HKD 0.071 on the date of the agreement [1] - The net proceeds from the placement are expected to be approximately HKD 12.37 million [1]
朸浚国际(01355.HK)拟折让约11.27%配售最多1.988亿股 净筹1237万港元
Ge Long Hui· 2025-09-08 12:15
Group 1 - The company, Puhua International (01355.HK), has entered into a placement agreement with a placement agent to issue up to 198,840,000 shares at a price of HKD 0.063 per share [1] - The placement price represents a discount of approximately 11.27% compared to the closing price of HKD 0.071 per share on the date of the agreement [1] - The net proceeds from the placement, after deducting related costs, are expected to be approximately HKD 12.37 million, which will be used for the further development of the company's healthcare and beauty business [1]
朸浚国际(01355) - 根据一般授权配售新股份
2025-09-08 12:09
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 (股份代號:1355) 根據一般授權配售新股份 配售代理 昌利證券有限公司 於二零二五年九月八日(交易時段後),本公司與配售代理訂立配售協議,據 此,本公司擬按唯一及獨家基準委任配售代理以竭盡全力基準配售及促使 認購配售股份,惟須遵守配售協議所載條款及條件。配售代理須促使不少於 六名承配人按配售價每股配售股份0.063港元認購最多198,840,000股配售股 份。 198,840,000股配售股份之上限數目相當於(i)於配售協議日期已發行股份總 數約19.99%;及(ii)經配發及發行198,840,000股配售股份後擴大之已發行股 份總數約16.66%。 本公告僅供參考,並不構成收購、購買或認購本公司任何證券之邀請或要約。 LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸濬國際集團控股有限公司 (於開曼群島註冊成立之有限公司 ...
朸浚国际(01355) - 2025 - 中期业绩
2025-09-01 08:33
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸濬國際集團控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:1355) 截至二零二五年六月三十日止六個月期間 之中期業績公告 朸濬國際集團控股有限公司(「本公司」)及其附屬公司(統稱「本集團」)董事 (「董事」)會(「董事會」)欣然宣佈本集團截至二零二五年六月三十日止六個 月期間之未經審核簡明綜合財務業績(「中期業績」)。本公告載列本公司截至 二零二五年六月三十日止六個月期間之中期報告(「中期報告」)全文,有關 內容乃根據香港聯合交易所有限公司(「聯交所」)證券上市規則之相關規定 而編製。中期業績已經董事會審核委員會審閱。本公告將刊登於本公司網站 (www.legend-strategy.com)及聯交所網站(www.hkexnews.hk)。中期報告的印刷 版本將適時寄 ...
朸浚国际(01355.HK):中期股东应占亏损为1348.4万港元
Ge Long Hui· 2025-08-29 14:50
Group 1 - The company reported a revenue of HKD 25.445 million for the six months ending June 30, 2025, representing a year-on-year increase of 33.2% [1] - The loss attributable to the company's owners was HKD 13.484 million, compared to a profit of HKD 3.211 million in the same period last year [1] - The basic loss per share was HKD 0.0165 [1]
朸濬国际发布中期业绩 股东应占亏损1348.4万港元 同比盈转亏
Zhi Tong Cai Jing· 2025-08-29 14:09
Group 1 - The company reported a revenue of HKD 25.445 million for the mid-year of 2025, representing a year-on-year increase of 33.19% [1] - The company experienced a loss attributable to shareholders of HKD 13.484 million, compared to a profit of HKD 3.211 million in the same period last year [1] - The basic loss per share was HKD 0.0165 [1]
朸濬国际(01355)发布中期业绩 股东应占亏损1348.4万港元 同比盈转亏
智通财经网· 2025-08-29 14:05
Group 1 - The company reported a revenue of 25.445 million HKD for the mid-year of 2025, representing a year-on-year increase of 33.19% [1] - The company experienced a loss attributable to shareholders of 13.484 million HKD, compared to a profit of 3.211 million HKD in the same period last year [1] - The basic loss per share was reported at 1.65 HKD cents [1]
朸浚国际(01355) - 2025 - 中期业绩
2025-08-29 13:16
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸濬國際集團控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:1355) 截至二零二五年六月三十日止六個月期間 之中期業績公告 朸濬國際集團控股有限公司(「本公司」)及其附屬公司(統稱「本集團」)董事 (「董事」)會(「董事會」)欣然宣佈本集團截至二零二五年六月三十日止六個 月期間之未經審核簡明綜合財務業績(「中期業績」)。本公告載列本公司截至 二零二五年六月三十日止六個月期間之中期報告(「中期報告」)全文,有關 內容乃根據香港聯合交易所有限公司(「聯交所」)證券上市規則之相關規定 而編製。中期業績已經董事會審核委員會審閱。本公告將刊登於本公司網站 (www.legend-strategy.com)及聯交所網站(www.hkexnews.hk)。中期報告的印刷 版本將適時寄 ...